Financial News
All News about Nextcure Inc
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease
September 05, 2023
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
From NextCure
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/16/aapharma_1.png?width=1200&height=800&fit=crop)
NextCure, LegoChem Biosciences Ink Collaborative Pact For Antibody Drug Conjugates
November 16, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2512.jpeg)
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3058.jpeg)
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
NextCure to Present at SVB Securities Global Biopharma Conference
February 07, 2023
From NextCure
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22463.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22357.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
NextCure to Present at Upcoming Investor Conferences
November 22, 2022
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21154.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20875.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/image_2.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20757.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/image-yelp.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
NextCure Appoints Dr. Lisa M. Coussens to Scientific Advisory Board
October 27, 2022
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
October 05, 2022
From NextCure
Via GlobeNewswire
![](https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.